{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:09:41Z","timestamp":1776438581633,"version":"3.51.2"},"reference-count":35,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health Research Translating Research into Policy (NIHR TRiP","award":["NIHR202094"],"award-info":[{"award-number":["NIHR202094"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,30]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We compared the cost-effectiveness of alternative fracture risk assessment strategies for people with intellectual disabilities (ID) aged \u226540 years from a UK National Health Services perspective over a lifetime horizon.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cost-effectiveness analysis using a lifetime decision-analytical model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>UK primary care, with data from literature and national databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>People with ID.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Three strategies were assessed: (S1) Risk assessment using the UK QFracture score; (S2) use of IDFracture (a fracture risk prediction tool specifically developed for adults with ID); and (S3) conducting a one-time dual-energy X-ray absorptiometry (DXA) scan in all. S1 and S2 were followed by DXA scan for those at risk. At-risk individuals received treatment according to UK practice (bisphosphonates plus vitamin D and calcium for osteoporosis, and vitamin D and calcium alone for osteopenia).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary outcome measures<\/jats:title>\n                    <jats:p>Direct healthcare costs and quality-adjusted life years (QALYs), and incremental cost-effectiveness ratio (ICER).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the base case, S2 (ICER: \u2212\u00a32568\/QALY) was dominant (ie, less costly and more effective) and S3 (ICER: \u00a31678\/QALY) was cost-effective relative to S1 for major osteoporotic fracture (MOF). For hip fracture, S2 (ICER: \u00a332 116\/QALY) and S3 (ICER: \u00a349 536\/QALY) were not cost-effective relative to S1 under the National Institute for Health and Care Excellence-recommended cost-effectiveness thresholds. Findings from the sensitivity analyses were predominantly consistent with the base-case results. Subgroup analyses showed that age-specific and gender-specific strategies could be used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For people with ID aged \u226540 years, a proactive approach to risk assessment for MOF is not only clinically beneficial, but also cost-effective.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-110008","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:25:15Z","timestamp":1776435915000},"page":"e110008","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness of osteoporotic fracture risk assessment in people with intellectual disabilities: a UK NHS modelling study"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5876-9363","authenticated-orcid":false,"given":"May Ee","family":"Png","sequence":"first","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Frighi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Oxford, Oxford, England, UK"},{"name":"Oxford Health NHS Foundation Trust, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1214-1682","authenticated-orcid":false,"given":"Tim Adrian","family":"Holt","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"},{"name":"Department of Psychiatry, University of Oxford, Oxford, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Achana","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0946-742X","authenticated-orcid":false,"given":"Margaret C","family":"Smith","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2772-2316","authenticated-orcid":false,"given":"Gary Stephen","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, England, UK"},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Roast","sequence":"additional","affiliation":[{"name":"Dimensions UK, Reading, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Petrou","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"2026041707251287000_16.4.e110008.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0172-4"},{"key":"2026041707251287000_16.4.e110008.2","unstructured":"International Osteoporosis Foundation . Epidemiology (Cambridge, Mass.), 2022. Available: https:\/\/www.osteoporosis.foundation\/health-professionals\/fragility-fractures\/epidemiology [Accessed 25 Nov 2022]."},{"key":"2026041707251287000_16.4.e110008.3","doi-asserted-by":"crossref","unstructured":"Greendale G , Barrett-Connor E . Outcomes of Osteoporotic Fractures. San Diego, CA: Academic Press, 2001:819\u201329.","DOI":"10.1016\/B978-012470862-4\/50035-0"},{"key":"2026041707251287000_16.4.e110008.4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101656","article-title":"Incidence of fractures in people with intellectual disabilities over the life course: a retrospective matched cohort study","volume":"52","author":"Frighi","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2026041707251287000_16.4.e110008.5","unstructured":"National Osteoporosis Guideline Group . Clinical guideline for the prevention and treatment of osteoporosis, 2021. Available: https:\/\/www.nogg.org.uk\/full-guideline [Accessed 25 Nov 2022]."},{"key":"2026041707251287000_16.4.e110008.6","unstructured":"Smith M , Roast J , Collins GS , et al . Development and external validation of prediction models for major osteoporotic fracture and hip fracture in people with intellectual disability. Osteoporos Int. (In Press)."},{"key":"2026041707251287000_16.4.e110008.7","unstructured":"National Institute for Health and Care Excellence . Osteoporosis - prevention of fragility fractures, 2023. Available: https:\/\/cks.nice.org.uk\/topics\/osteoporosis-prevention-of-fragility-fractures\/ [Accessed 22 May 2023]."},{"key":"2026041707251287000_16.4.e110008.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.10.008"},{"key":"2026041707251287000_16.4.e110008.9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3427","article-title":"Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study","volume":"344","author":"Hippisley-Cox","year":"2012","journal-title":"BMJ"},{"key":"2026041707251287000_16.4.e110008.10","unstructured":"National Institute for Health and Care Excellence . Osteoporosis: assessing the risk of fragility fracture, 2017. Available: https:\/\/www.nice.org.uk\/guidance\/cg146 [Accessed 7 May 2024]."},{"key":"2026041707251287000_16.4.e110008.11","unstructured":"National Institute for Health and Care Excellence . Osteoporosis - prevention of fragility fractures: Scenario: Assessment, 2025. Available: https:\/\/cks.nice.org.uk\/topics\/osteoporosis-prevention-of-fragility-fractures\/management\/assessment\/ [Accessed 20 Aug 2025]."},{"key":"2026041707251287000_16.4.e110008.12","unstructured":"Frighi V , Andrews T , Clifton L , et al . Fractures in people with intellectual disabilities: comparison with the general population and development of a fracture risk calculator specific to these patients, 2018. Available: https:\/\/cprd.com\/protocol\/fractures-people-intellectual-disabilities-comparison-general-population-and-development [Accessed 28 Nov 2022]."},{"key":"2026041707251287000_16.4.e110008.13","unstructured":"Scottish Intercollegiate Guidelines Network . Management of osteoporosis and the prevention of fragility fractures. SIGN142. 2021. Available: https:\/\/www.sign.ac.uk\/media\/1812\/sign-142-osteoporosis-v3.pdf [Accessed 22 May 2023]."},{"key":"2026041707251287000_16.4.e110008.14","unstructured":"NHS Digital . Hospital episode statistics (HES). 2022. Available: https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics [Accessed 18 Mar 2022]."},{"key":"2026041707251287000_16.4.e110008.15","unstructured":"Clinical Practice Research Datalink . Primary care data for public health research, 2022. Available: https:\/\/cprd.com\/primary-care [Accessed 18 Mar 2022]."},{"key":"2026041707251287000_16.4.e110008.16","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum","volume":"48","author":"Wolf","year":"2019","journal-title":"Int J Epidemiol"},{"key":"2026041707251287000_16.4.e110008.17","unstructured":"Bone Health & Osteoporosis Foundation . Evaluation of Bone Health\/Bone Density Testing, 2022. Available: https:\/\/www.bonehealthandosteoporosis.org\/patients\/diagnosis-information\/bone-density-examtesting\/ [Accessed 23 May 2023]."},{"key":"2026041707251287000_16.4.e110008.18","unstructured":"National Osteoporosis Guideline Group . Clinical guideline for the prevention and treatment of osteoporosis, 2021. Available: https:\/\/www.nogg.org.uk\/full-guideline [Accessed 7 May 2024]."},{"key":"2026041707251287000_16.4.e110008.19","unstructured":"National Institute for Health and Care Excellence . Bisphosphonates for treating osteoporosis, 2017. Available: www.nice.org.uk\/guidance\/ta464 [Accessed 28 Oct 2021]."},{"key":"2026041707251287000_16.4.e110008.20","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.113.143511"},{"key":"2026041707251287000_16.4.e110008.21","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2405"},{"key":"2026041707251287000_16.4.e110008.22","doi-asserted-by":"crossref","unstructured":"Janssen B , Szende A . Self-reported population health: an international perspective based on eq-5d . In: Szende A , Janssen B , Cabases J , eds. Population Norms for the EQ-5D. Dordrecht: Dordrecht: Springer Netherlands, 2014: 19\u201330. Available: http:\/\/link.springer.com\/10.1007\/978-94-007-7596-1","DOI":"10.1007\/978-94-007-7596-1_3"},{"key":"2026041707251287000_16.4.e110008.23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00198-017-4317-4","article-title":"Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS","volume":"29","author":"Svedbom","year":"2018","journal-title":"Osteoporos Int"},{"key":"2026041707251287000_16.4.e110008.24","unstructured":"National Health Service . 2021\/22 national cost collection data publication. 2024. Available: https:\/\/www.england.nhs.uk\/publication\/2021-22-national-cost-collection-data-publication\/ [Accessed 7 May 2024]."},{"key":"2026041707251287000_16.4.e110008.25","unstructured":"NHS Business Services Authority . Prescription cost analysis \u2013 England \u2013 2021\/22. 2022. Available: https:\/\/www.nhsbsa.nhs.uk\/statistical-collections\/prescription-cost-analysis-england\/prescription-cost-analysis-england-202122 [Accessed 7 May 2024]."},{"key":"2026041707251287000_16.4.e110008.26","unstructured":"Jones KC , Weatherly H , Birch S , et al . Unit costs of health and social care 2022. 2023."},{"key":"2026041707251287000_16.4.e110008.27","unstructured":"National Institute for Health and Care Excellence . NICE health technology evaluations: the manual. 2022. Available: https:\/\/www.nice.org.uk\/process\/pmg36\/chapter\/introduction-to-health-technology-evaluation [Accessed 23 Feb 2022]."},{"key":"2026041707251287000_16.4.e110008.28","unstructured":"National Institute for Health and Care Excellence . Guide to the methods of technology appraisal 2013, 2013. Available: https:\/\/www.nice.org.uk\/process\/pmg9\/resources\/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781 [Accessed 3 Oct 2019]."},{"key":"2026041707251287000_16.4.e110008.29","unstructured":"National Institute for Health and Care Excellence . The social care guidance manual. 2016. Available: https:\/\/www.nice.org.uk\/process\/pmg10\/resources\/ [Accessed 8 Apr 2022]."},{"key":"2026041707251287000_16.4.e110008.30","unstructured":"R Core Team . R: A language and environment for statistical computing. 2025."},{"key":"2026041707251287000_16.4.e110008.31","doi-asserted-by":"publisher","DOI":"10.1016\/J.BONE.2007.10.019"},{"key":"2026041707251287000_16.4.e110008.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-020-05765-7"},{"key":"2026041707251287000_16.4.e110008.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2008.00497.x"},{"key":"2026041707251287000_16.4.e110008.34","doi-asserted-by":"publisher","DOI":"10.1192\/BJP.2019.204"},{"key":"2026041707251287000_16.4.e110008.35","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2232-2"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-110008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:25:26Z","timestamp":1776435926000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-110008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,17]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjopen-2025-110008"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-110008","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}